ClinicalTrials.gg
RecruitingNCT06364644UNLOAD-HFUpdated Oct 14, 2026

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

An interventional study of Community Champions and Homegrown Heroes in Type2diabetes, Heart Failure and Obesity, sponsored by Johns Hopkins University. Recruiting at 2 sites in United States. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Updated Oct 14, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
156
Allocation
Randomized
Ages
30 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Heart Failure by Johns Hopkins University — 6 open to participants now, 7 under way, none of them phase 3. Heart Failure · Johns Hopkins University.

Planned enrollment
3rd of 11
156 · median 29
Started
2025
the only one that year
No phase
6 of 21
1 open now
Registered
19th of 21
by date

Among the 21 studies in Heart Failure by Johns Hopkins University, this one is the 3rd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2025, is one of 6 with no phase, and was the 19th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

6 of the 21 studies in Heart Failure by Johns Hopkins University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 30 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Heart Failure by Johns Hopkins University, or all of them as a file.
02

Study summary

This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dysfunction than receiving education and access to a community exercise facility.

Read the detailed description

This randomized controlled trial employs a 2:1 allocation ratio. The study aims to include 156 individuals from Baltimore City and Hagerstown, Maryland, characterized by low neighborhood and individual socioeconomic status, type 2 diabetes, obesity, and evidence of subclinical heart dysfunction, without a prior clinical diagnosis of heart failure. The 6-month multi-level intervention consists of three key components:

  1. Problem Solving - Diabetes Self-Management Training (DECIDE): Participants will engage in a biweekly evidence-based behavioral change program known as DECIDE. This program focuses on problem-solving training, aiding individuals in managing chronic conditions by overcoming obstacles and challenges. It aims to enhance self-care, improve control of metabolic risk factors, and includes tailored education on heart failure prevention.
  2. Community Health Worker Support: Participants will receive ongoing support from community health workers as part of the intervention. These workers will conduct telephone and/or home visits at least monthly, offering assistance in following areas:

    • Reinforcing patient education about disease self-management
    • Helping patients access care and addressing barriers to care and treatment
    • Serving as facilitators and navigators to clinical care, social services, and other community resources
    • Providing encouragement and support to engage, activate, and empower patients and their support systems
  3. Health Coaching and Partnership with Community Facilities: Participants will engage in supervised aerobic and resistance exercise training at the local Young Men's Christian Associations (YMCAs). The participants will receive instructions on gradually increasing the activity levels throughout the 6-month intervention to achieve physical activity goals (150 minutes of moderate to vigorous exercise per week).
03

Conditions studied

  • Type2diabetes
  • Heart Failure
  • Obesity

Keywords

  • Behavioral Intervention
  • Diabetes
  • Heart Failure
  • Exercise
  • Obesity
  • Health Equity
  • Low Socioeconomic Status
04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults from Johns Hopkins Medicine (JHM) who live in Baltimore City and adults from Johns Hopkins Community Physicians (JHCP) Hagerstown or Family Healthcare of Hagerstown who live in Washington County
  • Low socioeconomic status (SES) by high Area Deprivation Index (ADI) [>75th percentile for the state of Maryland] plus low income)
  • Type 2 diabetes
  • Obesity (≥30 kg/m\^2)

Exclusion criteria

Exclusion Criteria:

  • Age \< 30 or >70 years
  • Prevalent heart failure
  • Uncontrolled glycemia (blood glucose \<60 mg/d or ≥ 300 mg/dl or most recent ≥11%)
  • Uncontrolled blood pressure (Systolic blood pressure (SBP) ≥160 or diastolic blood pressure (DBP) ≥100 mm Hg, either on or off medications)
  • Known coronary artery disease (unless \< 50% stenosis by angiography)
  • Moderate or severe valvular heart disease
  • Serious medical conditions limiting or requiring active management
  • Inability to participate in moderate intensity physical activity as assessed by the self-report Physical Activity Readiness Questionnaire Plus (PAR-Q+).
  • Any condition or planned surgery/procedure precluding exercise for ≥ 150 minutes per week
  • End-stage renal disease
  • Current participation in another behavior change program
  • Active alcohol or substance abuse disorder
  • Already engaging in regular exercise with more than 60 minutes of moderate [3-6 METS] to vigorous [>6 METS] physical activity per week
  • Active pregnancy
  • Evidence of ischemia, dangerous arrhythmia, or other clinical instability on baseline exercise stress test
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
156 participants (estimated)

Study arms

  • Experimental
    Community Champions

    Participants assigned to the "Community Champions" group will undergo a six-month behavioral intervention. This intervention involves bi-weekly problem-solving training sessions (DECIDE) conducted in groups of 6-10 individuals, along with support from community health workers. Additionally, participants will receive a YMCA membership to exercise with a professional health coach.

    Behavioral: Community Champions

  • Active comparator
    Homegrown Heroes

    Participants assigned to the "Homegrown Heroes" will receive a YMCA membership for exercise and a monthly newsletters for 6 months that include education about diabetes self-management, healthy lifestyle and heart failure prevention .

    Behavioral: Homegrown Heroes

Interventions

  • BehavioralCommunity Champions

    The UNLOAD-Heart Failure Program intervention includes problem solving training, community health worker support, and exercise support from health coaches at YMCAs.

    Also known as: Multi-level intervention

  • BehavioralHomegrown Heroes

    Monthly newsletters/videos on diabetes self-management, healthy lifestyle and heart failure prevention will be provided, as well as a membership to the local YMCA.

    Also known as: Education plus access to community exercise facility

06

What researchers measure

Primary outcomes

  1. Change in fitness as assessed by the 6 minute walk test

    Total distance walked in the 6 minutes walk test in meters

    Time frame: Baseline and 6 month follow up

Secondary outcomes

  1. Change in cardiac biomarker, high-sensitivity cardiac troponin-T (hs-cTnT)

    Percent change from baseline in hs-cTnT

    Time frame: Baseline and 6 month follow up

  2. Change in hemoglobin A1c

    Absolute change from baseline in hemoglobin A1c

    Time frame: Baseline and 6 month follow up

  3. Change in specific problem solving skills as assessed by Health Problem-Solving Scale (HPSS) subscales.

    The following Health Problem-Solving Scale (HPSS) subscales will be assessed: Impulsive/Careless Problem Solving (IPS), Avoidant Problem Solving (APS), Negative Transfer (NTR), Negative Motivation/Orientation (NMO). Subscale scores are calculated by summing the scores for each item within the respective subscales. Higher subscale scores indicate more of that problem-solving characteristic. The score range for each subscale is as follows: IPS (0-32), APS (0-28), NTR (0-44), NMO (0-20). Total score range 0-124.

    Time frame: Baseline, 6 month follow up, 12 month follow up

  4. Changes in self care measures as assessed by Summary of Diabetes Self-Care Activities Scale (SDSCA)

    The Summary of Diabetes Self-Care Activities Scale (SDSCA) is a tool used to measure diabetes self-care activities. 12-items with 5 sub-scales (diet, exercise, home blood glucose testing, foot care, smoking status). The respondent is asked how many days in the past week the behavior was performed (ranges from 0 to 7); The result is an average score between 0 and 7 with higher score indicating better diabetes self-management behavior.

    Time frame: Baseline, 6 month follow up, 12 month follow up

  5. Changes in disease knowledge as assessed by Diabetes and Cardiovascular Disease (CVD) Knowledge Test

    The Diabetes and CVD Knowledge Test comprises 16 items, featuring both multiple-choice and true-or-false questions. This assessment tool gauges individuals' comprehension of diabetes, its impact on health, and optimal strategies for managing the condition. The possible score range is 0-17. A higher score indicates a better understanding of diabetes and cardiovascular disease.

    Time frame: Baseline, 6 month follow up, 12 month follow up

  6. Changes in physical activity as assessed by Modified Physical Activity Questionnaire (MPAQ)

    The MPAQ is a tool used to estimate the frequency in days (number of times per month) and in time (minutes) someone participated in physical activity (e.g. biking, walking, swimming, etc.). Hours per week for all activities are summed to determine activity hours per week averaged over the past year. A higher sum indicates more physical activity. Values can also be weighted by their estimated metabolic cost and expressed as metabolic equivalent (MET) hours per week. Higher METs are associated with better outcomes. The MPAQ also assesses inactivity, such as the average number of hours per day spent watching television or being confined to a bed or chair for more than 1 week. A higher average indicates less physical activity.

    Time frame: Baseline, 6 month follow up, 12 month follow up

  7. Change in weight (kgs)

    Change from baseline in weight (kgs)

    Time frame: Baseline and 6 month follow-up

  8. Change in BMI

    Change from baseline in BMI (Kg/m\^2).

    Time frame: Baseline and 6 month follow-up

  9. Change in hip and waist circumference (centimeters)

    Change from baseline in hip and waist circumference (centimeters)

    Time frame: Baseline and 6 month follow up

  10. Change in Metabolic Syndrome Severity Z score

    Metabolic Syndrome Severity (MetS) Z score calculates an individual's metabolic syndrome severity score by examining five key markers: waist circumference, blood pressure, triglycerides, HDL, and fasting glucose. Score typically ranges from -5 to 5. Higher scores indicate greater metabolic syndrome severity.

    Time frame: Baseline and 6 month follow up

  11. Change in self-management as assessed by the Patient Activation Measure (PAM-13).

    The Patient Activation Measure is a 13-item survey that will assess an individual's knowledge, skills and confidence to managing one's health and healthcare. The PAM scores is calculated and then transformed to a scale with a range from 0-100. A higher PAM score indicates higher patient activation. The score can also be converted into four activation levels: 1 - not believing activation important, 2 - lack of knowledge and confidence to take action, 3 - beginning to take action, 4 - taking action.

    Time frame: Baseline, 6 month follow up,12 month follow up

  12. Change in quality of life and overall health and well-being as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health 10

    The PROMIS Global Health 10 survey comprises 10 items designed to evaluate both physical and mental health status. Scores are aggregated separately for physical and mental health, each ranging from 4 - 20. Higher scores in both categories indicate better outcomes.

    Time frame: Baseline, 6 month follow up,12 month follow up

  13. Change in blood pressure (systolic and diastolic (mmHg))

    changes in blood pressure from baseline

    Time frame: Baseline and 6 month follow up

  14. Change in cardiac biomarker, gal-3

    Percent change from baseline in gal-3

    Time frame: Baseline and 6 month follow up

  15. Change in cardiac biomarkers, NT-proBNP

    Percent change from baseline in NT-proBNP

    Time frame: Baseline and 6 month follow up

  16. Change in post-walk Borg dyspnea scale

    Changes in post-walk Borg dyspnea scale which ranges from 0 ("no shortness of breath") to 10 ("worst possible shortness of breath"); higher score worse breathing difficulty. Measured in a subset of the population.

    Time frame: Baseline and 6 month follow up

  17. Change in cardiorespiratory fitness as assessed by peak oxygen uptake (V02 peak)

    Change in peak oxygen uptake (VO2 peak) as assessed by a cardiopulmonary fitness test in a subset of the population.

    Time frame: Baseline and 6 month follow up

07

Study locations

1 of 2 sites recruiting
  • Johns Hopkins Center for Health Equity
    Baltimore, Maryland 21205, United States
    Recruiting
  • Johns Hopkins University Comstock Center
    Hagerstown, Maryland 21740, United States
    Not yet recruiting
    • Melissa Minotti, MPH, RPSGT, CCRC · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Sep 2027, 27 months after the start.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 27 months is close to that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 14, 2026: primary completion Sep 2026 → Sep 2027 and completion Mar 2027 → Sep 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2024
First posted
Apr 15, 2024
StartActual
Jun 20, 2025
Primary completionEst.
Sep 2027was Sep 2026
CompletionEst.
Sep 2027was Mar 2027
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 2026→Sep 2027
Oct 14, 2026
Study completion
Mar 2027→Sep 2027
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    Primary completion Sep 2026→Sep 2027
    Study completion Mar 2027→Sep 2027
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06364644
Responsible party
Sponsor
First posted
Apr 15, 2024
Start date
Jun 20, 2025
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Oct 14, 2026

Study contacts

Chiadi Ndumele, MD, PhD
Contact
cndumel2@jhmi.edu
4105022319
Perri Carroll, MPH
Contact
pcarro13@jhmi.edu
4436927272
Chiadi Ndumele, MD, PhD
principal investigator · Johns Hopkins School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion